When it comes to anticancer drugs, I have a deep understanding. I have been a graduate student for three years, and I have worked hard for three years. Before graduation, I have completed the research in the laboratory stage, and I am still a long way from becoming a drug. Medical devices are indeed faster than drugs, which may be mainly due to the following aspects:
The research and development cycle and difficulty are different
Usually, a drug includes anti-tumor drugs, and the research and development cycle is usually 8-14 years, especially the research and development of new anti-cancer drugs, which has a high failure rate, and must go through phase I, II and III clinical trials and be verified by a large number of people before it can be listed.
Medical devices are different. There are three types of medical devices. Only two or three types need some clinical trials, but they are only verified by small samples. Moreover, most of the hospital's inspection equipment belongs to auxiliary diagnosis or inspection equipment, which generally belongs to a class of medical devices, and clinical trials are not needed, so the overall cycle is not a week and a half.
Different technical barriers
The listing of a brand-new anticancer drug has attracted worldwide attention. Pharmaceutical companies also adopt strong patents and technical barriers, which almost seal any gaps related to them and do not exploit loopholes for others. Even if some people bypass the patent, they mostly copy it on the basis of others. Moreover, few generic drugs are more effective than the original drugs. In this way, although patients can choose more drugs, they have not actually made progress.
unlike medical devices, the core technology involves physics, chemistry, mathematics, biology, medicine, and even machinery, engineering and other fields. Technological innovation in any field may promote a certain type of medical devices to a higher level. For example, nanotechnology, 3D printing technology and so on.
the price problem
the research and development of new drugs can be described as a narrow escape. New drug researchers have spent a lot of manpower and financial resources, taking a lot of risks of investment failure, and only then can a new drug be successfully listed, which can be imagined as expensive. However, medical devices are usually developed based on new technologies that have been formed, and the success rate is high. Because it is only used for inspection and can be reused, the charging standard is stipulated by the state and there is great market competition, so the inspector will not bear the high price.
profile of Dr. Yao
Dr. Yao, deputy director pharmacist and senior nutritionist, has 11 years of experience in medication guidance, nutrition consultation and health management. No medicine, no medicine, advocate healthy life, no illness, no medicine!